The first new Alzheimer’s drug approved for use in Australia in 25 years, ticked off by the Therapeutic Goods Association in ...

Don't assume Alzheimer's only affects the elderly. Learn about early-onset Alzheimer's, its unique symptoms, and how a ...

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

Early-onset Alzheimer’s is often more difficult to diagnose and manage due to the relatively young age of the individuals ...

In 1964, a 17-year-old student named Randy Gardner set a world record by staying awake for over 11 days as part of a science ...

For decades, scientists believed fat in the brain was little more than a by-product of neurodegenerative diseases like Alzheimer’s. But new research from Purdue University is overturning that ...

With amyloid immunotherapy in clinical use, scientists need to find better ways to identify the patients most at risk of developing ARIA (see part 16 of this series). One of the biggest danger signs, ...

A full night of deep sleep is not a luxury – it might be a shield. New research suggests that the right kind of sleep can help ward off memory trouble in people whose brains already show signs of ...

While amyloid immunotherapy is slowly becoming more accepted in clinical use, its biggest drawback remains the risk of ARIA. Scientists continue to study which patients are most at risk, how to ...

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, is proud to announce that its early achievements while ...

People who inherit two copies of a gene variant called APOE4 have a 60% chance of developing Alzheimer’s by age 85. Only about 2% to 3% of people in the U.S. have this genetic profile, and most of ...